Xbiotech Inc Growth Comparisons

Select each growth Category to receive further Information

Select the Comparisons :

Growth Rates ▼

Select the Ratio:

None▼

Growth Rates ▼

None▼

Download as CSV

XBIT Revenue Growth Rate Comparisons	Company	Industry	Sector	S&P 500
Y / Y Revenue Growth (Q2 MRQ)	-	8.14 %	5.99 %	4.7 %
Q / Q Revenue Growth (Q2 MRQ)	-	9.68 %	5.87 %	4.11 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM)	-	8.96 %	5.75 %	%
Sequential Revenue Growth (for 12 months ending Q2 TTM)	-	2 %	1.39 %	1.17 %
Revenue 5 Year Average Growth	-	8.99 %	8.21 %	7.56 %

XBIT's Growth Comparisons in II. Quarter 2025

Xbiotech Inc reported top-line of $ 0 millions in the second quarter 2025, compare to $ 0 millions in the same quarter a year ago. Revenues in the Major Pharmaceutical Preparations industry grew by 8.14%, while the top-line in the Healthcare sector increased by 5.99%, and overall market improved by 4.7% from the second quarter 2024.

Sequentially company's Revenue were unchanged from the first quarter results. . Looking into annual growth, sales grew by % on average in last five years, while S & P 500's including only Businesses with the second quarter 2025 earnings reports, average yearly sales growth is 7.56%.

XBIT Growth Rates by Company's Segments

Segment Name

Y / Y

Sequential

Growth Rates of XBIT's Income in the second quarter 2025

XBIT Operating Income Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Operating Income Change (Q2 MRQ)	-	68.15 %	57.81 %	10.32 %
Sequential Operating Income Change (Q2 MRQ)	-	21.2 %	15.93 %	4.92 %
Y / Y Operating Income Growth (Q2 TTM)	-	120.39 %	69.09 %	3.22 %
Sequential Operating Income Growth (Q2 TTM)	-	15.3 %	12.78 %	0.95 %
Operating Income 5 Year Avg. Change	-	-2.03 %	-2.02 %	9.12 %

Income from Cont. Ops. Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ)	-	104.68 %	161.62 %	6.6 %
Sequential Income from Cont. Ops. Change (Q2 MRQ)	-	0.56 %	7.49 %	6.18 %
Y / Y Income from Cont. Ops. Change (Q2 TTM)	-	182.01 %	167.85 %	9.77 %
Sequential Income from Cont. Ops. Change (Q2 TTM)	-	19.35 %	24.84 %	1.93 %
Income from Cont. Ops. 5 Year Avg. Change	-	-4.01 %	-9.4 %	9.11 %

XBIT Net Income Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y Net Income Growth (Q2 MRQ)	-	105.73 %	152.67 %	8.18 %
Q / Q Net Income Growth (Q2 MRQ)	-	1.2 %	6.95 %	6.45 %
Y / Y Net Income Change (Q2 TTM)	-	51.6 %	70.08 %	9.28 %
Sequential Net Income Change (Q2 TTM)	-	19.6 %	23.27 %	2.32 %
Net Income 5 Year Avg. Growth	-	-5 %	-8.86 %	8.67 %

XBIT's EPS Growth Rates

EPS from Cont. Ops. Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ)	-	98.43 %	161.62 %	6.6 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ)	-	0.08 %	7.49 %	6.18 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM)	-	-	-	-
Sequential EPS from Cont. Ops. Change (Q2 TTM)	-	-	-	-37.11 %
EPS from Cont. Ops. 5 Year Avg. Growth	-	-12.1 %	-9.4 %	9.11 %

XBIT EPS Net Growth Rates Comparisons	Company	Industry	Sector	S&P 500
Y / Y EPS Net Growth (Q2 MRQ)	-	99.45 %	152.67 %	9.11 %
Q / Q EPS Net Growth (Q2 MRQ)	-	0.71 %	6.95 %	6.45 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM)	-	-	-	-40.33 %
Sequential EPS Net Change (for 12 months ending Q2 TTM)	-	-	-	-37.11 %
EPS Net 5 Year Avg. Change	-	-5 %	-8.86 %	8.67 %

Xbiotech Inc reported bottom-line of $ -0.06 in the second quarter, compare to $ -0.43 in the same quarter a year ago. Major Pharmaceutical Preparations industry grew by 99.45%, while Healthcare sector increased by 152.67%, and overall market improved by 8.18%.

Sequentially company's EPS were unchanged from the first quarter results. . Looking into annual growth, income per share grew by % on average in the last five years, while the S & P 500's including only the businesses with the second quarter 2025 financial results, average yearly income per share growth is 8.67%.

XBIT Cash Flow Growth Rates

Free Cash Flow Growth Rates	Company	Industry	Sector	S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ)	-	54.6 %	27 %	-8.64 %
Sequential Free Cash Flow Change (Q2 MRQ)	-	42.43 %	48.41 %	1421.99 %
Y / Y Free Cash Flow Change (Q2 TTM)	-	22.39 %	19.3 %	-5.86 %
Sequential Free Cash Flow Change (Q2 TTM)	-	7.24 %	4.11 %	-0.64 %
Free Cash Flow 5 Year Avg. Change	-	8.78 %	4.62 %	8.25 %

Net Cash Flow Growth Rates	Company	Industry	Sector	S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ)	-	-	-	-
Sequential Net Cash Flow Change (Q2 MRQ)	-	-	-	-
Y / Y Net Cash Flow Change (Q2 TTM)	-	-	-	-
Sequential Net Cash Flow Change (Q2 TTM)	-	-	-	-
Net Cash Flow 5 Year Avg. Change	-	-31.61 %	-19.62 %	0.44 %

Capital Expenditures	Company	Industry	Sector	S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ)	-91.87 %	14.05 %	3.21 %	17.12 %
Sequential Capital Expenditures Change (Q2 MRQ)	-45.74 %	-0.2 %	2.58 %	10.67 %
Y / Y Capital Expenditures Change (Q2 TTM)	-44.95 %	11.97 %	7.51 %	16.6 %
Sequential Capital Expenditures Change (Q2 TTM)	-50.39 %	3.56 %	0.68 %	4.06 %
Capital Expenditures 5 Year Avg. Change	44.92 %	9.47 %	8.03 %	7.55 %

Note
To view Detail Information & Trends click on Individual Category. Example: Y / Y Revenue Change (MRQ) or To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table. Example: Industry Sector S&P 500 For explanation of terms visit: Glossary

Valuation Comparisons

Management Effectiveness

Financial Strength

Efficiency

Dividend Comparisons

Help

About us

Terms of Use

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.